• SENSEX 76,295.36
    -322.08 (--0.42%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Mazagon Dock
    2,750.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Hind.Aeronautics
    4,328.95 5,675.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • TCS
    3,396.10 3,396.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,764.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    652.80 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Angel One
    2,475.00 3,502.60(%)
  • Jio Financial
    231.75 394.70(%)
  • HDFC Bank
    1,776.70 1,430.15(%)
  • Nippon ETF Liq.
    1,000.01 1,005.00(%)
  • Reliance Power
    44.44 54.25(%)
  • Zomato Ltd
    208.35 146.85(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Emcure Pharma
    1,025.75 911.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

NGL Fine Chem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4558.0
  • ISIN : INE887E01022
1,125.00 -4 (-0.35%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    1,106.45

  • Today’s High

    1,135.10

  • Open

    1,135.10

  • Perv Close

    1,129.00

  • 52W Low

    957.00

  • 52W High

    2,823.90

Key Indicators

  • P/E(TTM)

    23.67

  • Mar.Cap (₹Cr.)

    695.25

  • Div & Yield %

    0.15

  • Book Value(₹)

    451.95

  • Debt-Equity Ratio

    -0.35

  • AGM Date

    03-Apr-2025

  • EPS

    47.74

  • P/E Ratio

    23.67

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    695.25

  • RONW (%)

    17.03

  • ROCE (%)

    20.16

Score Board

  • Equity (₹ in Cr.)

    3.09

  • BV (₹)

    452.00

  • Sales( ₹ in Cr.)

    328.97

  • NP (in Cr.)

    38.52

  • NP Var(%)

    91.0

  • Div%

    35.0

  • CPS (₹)

    75.50

  • EPS (₹)

    62.30

  • Traded Value (₹ in Lakhs)

    698.31

  • 52 Week High

    2,823.90

  • 52 Week Low

    957.00

  • Price BSE

    1130.0

  • Price NSE

    1,125.00

  • Market Capital( in Cr.)

    698.31

  • P/C Ratio

    15.00

  • P/E Ratio

    18.10

  • Price Vs.BV

    62.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 328.97 275.05 318.67 258.18 152.18 153.17
Excise Duty 324.21 269.61 313.99 255.21 149.45 150.78
Net Sales 328.97 275.05 318.67 258.18 152.18 153.17
Other Income 15.90 7.61 12.64 8.55 3.34 4.12
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 344.87 282.66 331.31 266.73 155.52 157.29
EXPENDITURE :
Raw Materials 324.21 269.61 313.99 255.21 149.45 150.78
Power & Fuel Cost 324.21 269.61 313.99 255.21 149.45 150.78
Employee Cost 41.32 34.25 33.05 27.24 23.81 21.16
Other Manufacturing Expenses 5.81 6.72 4.93 2.34 5.56 1.71
Selling & Administrative Expenses 14.51 11.24 8.56 11.52 7.94 10.22
Miscellaneous Expenses 5.81 6.72 4.93 2.34 5.56 1.71
Less : Pre-operative Expenses Capitalised :
Total Expenditure 294.17 256.07 262.33 190.73 141.16 129.73
Operating Profit 68.51 54.89 58.25 37.90 29.52 25.42
Interest 1.34 1.20 1.56 1.84 2.25 2.29
Gross Profit 50.71 26.60 68.97 76.00 14.35 27.57
Depreciation 8.15 7.90 7.67 7.39 7.27 6.30
Profit Before Tax 50.71 26.60 68.97 76.00 14.35 27.57
Tax 11.13 7.20 17.15 19.12 4.84 7.80
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.78 -0.73 -0.42 1.46 -1.19 -0.58
Reported Net Profit 38.52 20.12 52.25 55.47 10.60 20.13
Extraordinary Items 50.71 26.60 68.97 76.00 14.35 27.57
Adjusted Net Profit 38.52 20.12 52.25 55.47 10.60 20.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 1.08 1.08 1.08 1.08 1.08 1.08
P & L Balance carried down 38.52 20.12 52.25 55.47 10.60 20.13
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 35.00 35.00 35.00 35.00 35.00 35.00
Dividend Per Share(Rs) 1.75 1.75 1.75 1.75 1.75 1.75
Earnings Per Share-Unit Curr 62.35 32.57 84.57 89.79 17.16 32.58
Book Value 1.08 1.08 1.08 1.08 1.08 1.08
Book Value(Adj)-Unit Curr 1.08 1.08 1.08 1.08 1.08 1.08

Shareholding Pattern

  • Promoter Group

    72.74%

  • Public Share Holding

    27.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 4,493,646 72.74 4,493,646 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,493,646 72.74 4,493,646 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,729 0.04 2,729 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 63 0.00 63 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,792 0.05 2,792 5
2] Non Institution
Bodies Corporate 124,313 2.01 115,513 93
Clearing Members 6,604 0.11 6,604 12
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 112,294 1.82 112,294 413
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 93,439 1.51 93,439 288
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 93,745 1.52 93,745 2
Individuals holding nominal share capital up to Rs. 1 lakh 1,247,079 20.19 1,054,832 13,280
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.02 1,000 2
Others 0 0.00 0 0
Sub Total 1,681,586 27.22 1,480,239 14,100
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,178,024 100.00 5,976,677 14,110

Company Background

NGL Fine Chem LtdPharmaceuticals - Indian - Bulk Drugs

  • NGL Fine Chem Ltd
  • BSE Code : 4558.0
  • ISIN : INE887E01022

  • Incorporation Year

    1981

  • Registered Office

    301 E Square Subhash Road
    Vile Parle (East), Mumbai,
    Maharashtra-400057

  • Telephone

    +91-22-2663 6450

  • FAX

  • Chairman

    Dhananjay Mungale

  • Managing Director

    Rahul J Nachane

  • Company Secretary

    Pallavi Pednekar

  • Auditor

    Manek & Associates

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (India) Pvt
    Shiv Shakti Indust,
    Unit No 9 Lower Pare,7 B J R Boricha Marg
    Mumbai - Mumbai-400011

NGL Fine Chem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
NGL Fine Chem 1,129.95 344.87 328.97 23.67 18.73
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92